MDH: Advisory 268 COVID-19 Home Test Kit Coverage (2024 UPDATE)

MDH Header

This Advisory is an update to Advisory 260.

Effective November 1, 2024, Maryland Medicaid will cover a maximum of two (2) FDA-approved
tests every rolling 30 days. Coverage of additional test kits exceeding the quantity limit described
above will require prior authorization. There will be a $1 copayment for a prescription as per COMAR
10.09.03.05.
The Pharmacists can continue to order test kits until December 31, 2024. Effective January 1, 2025,
all COVID-19 Home Test Kits will require a prescription.

This Advisory applies to Participants enrolled in the Maryland Fee-for-Service (FFS) program and
Participants enrolled in Managed Care Organizations (MCOs) that participate in the Maryland
HealthChoice Program.